- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: NSCLC Non-small cell lung cancer
Total 157019 results
-
Hoffmann-La RocheRecruitingNeoplasmsItaly, France, Turkey, Korea, Republic of, Spain, China, United States, Hong Kong, Russian Federation, Poland
-
Betta Pharmaceuticals Co., Ltd.RecruitingNon-small Cell Lung CancerChina
-
Inspirna, Inc.RecruitingLung Cancer | Endometrial Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Carcinoma | Endometrial Cancer Recurrent | Lung Cancer RecurrentUnited States
-
Merus N.V.RecruitingNSCLC Harboring NRG1 Fusion | Solid Tumours Harboring NRG1 Fusion | Pancreatic Cancer Harboring NRG1 Fusion | NRG1 FusionSpain, France, Israel, Belgium, Denmark, United States, Korea, Republic of, Japan, Germany, Netherlands, Austria, Canada, Italy, Norway, Singapore, Sweden, Taiwan, United Kingdom
-
Beijing Haidian Hospital307 Hospital of PLA; Peking University People's Hospital; 309th Hospital of Chinese...RecruitingThe Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR MutationNon-small Cell Lung Cancer(NSCLC)China
-
Tesaro, Inc.RecruitingNeoplasmsUnited States, Italy, Spain, Korea, Republic of, Canada, France, United Kingdom, Poland, Mexico, Czechia, Denmark, Argentina, Brazil
-
AIO-Studien-gGmbHBristol-Myers Squibb; Eli Lilly and Company; Merck Sharp & Dohme LLC; Pfizer; Gilead... and other collaboratorsRecruitingSmall-cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Non-small Cell Lung Cancer Stage I | Metastatic Non-small Cell Lung Cancer (NSCLC) | Non Small Cell Lung Cancer Stage III | Non-small Cell Lung Cancer Stage IIGermany
-
State University of New York - Upstate Medical...RecruitingNon-small Cell Lung CancerUnited States
-
Erasmus Medical CenterRecruitingNon-small Cell Lung CancerNetherlands
-
Sun Yat-sen UniversityRecruitingNon-small Cell Lung Cancer (NSCLC) | EGFR-TKI Resistant Mutation | EGFR-TKI Sensitizing Mutation | Somatic Mutation | Germline MutationsChina
-
Sun Yat-sen UniversityWu Jieping Medical FoundationRecruitingNon-small Cell Lung Cancer | Brain Metastases | EGFR MutationChina
-
Olivera FinnRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina, Israel, United States, Australia, Canada, Colombia, Estonia, France, Hungary, Italy, Japan, Korea, Republic of, Malaysia, Mexico, Poland, Russian Federation, Taiwan, Turkey, Ukraine
-
BeiGeneActive, not recruitingNSCLC | Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Canada, Belgium, China, Denmark, Spain, Thailand, United Kingdom, Taiwan, Brazil, Germany, Mexico, Italy, Switzerland, Hong Kong, Japan, France, Turkey, New Zealand, Poland
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, United Kingdom, Australia, Belgium, Brazil, Canada, China, Portugal, Spain, France, Germany, Poland, Hong Kong, Israel, Thailand, Turkey, Japan, Austria, Hungary, Italy, Taiwan, Netherlands, Greece, New... and more
-
Hunan Province Tumor HospitalCompletedNon-small Cell Lung CancerChina
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
Novartis PharmaceuticalsTerminatedMelanoma | Non-Small Cell Lung CancerItaly, Australia, Belgium, Germany, Spain, Korea, Republic of, Israel, France, United States, Sweden, Poland
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyActive, not recruitingSolid TumorsKorea, Republic of, United States, Spain, United Kingdom, Russian Federation, Argentina, Australia, Italy, Japan, Belgium, Brazil, Czechia, France, Germany, Hungary, Romania, Turkey, Bulgaria, Mexico, Poland, Thailand, Ukraine
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina
-
AbbVieActive, not recruitingCancer | Advanced Solid Tumors | Metastatic Solid Tumors | Triple-Negative Breast Cancer (TNBC) | Non-small-cell-lung-cancer (NSCLC)United States, Australia, France, Israel, Spain, Taiwan
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerDenmark, Italy, Spain, United States, Korea, Republic of, Japan, Netherlands, Norway, Sweden
-
Xcovery Holdings, Inc.Active, not recruitingNon-small Cell Lung CancerSpain, United States, China, Korea, Republic of, Hong Kong, United Kingdom, Poland, Israel, Germany, France, Argentina, Australia, Brazil, Canada, Czechia, Italy, Netherlands, Russian Federation, Turkey, Belgium
-
Icahn School of Medicine at Mount SinaiBristol-Myers Squibb; Traws Pharma, Inc.CompletedAdenocarcinoma | Non-small Cell Lung Cancer | Stage IVUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
BeiGeneCompletedNon-small Cell Lung CancerChina, Russian Federation, New Zealand, Lithuania, Turkey, Brazil, Bulgaria, Poland, Mexico, Slovakia
-
PfizerActive, not recruitingNon-small-cell Lung Cancer | Advanced MalignanciesChina, Korea, Republic of, Taiwan, Japan, Russian Federation, Ukraine
-
Washington University School of MedicineEli Lilly and CompanyCompletedNSCLC | Non Small Cell Lung Cancer | Non-small Cell Lung CancerUnited States
-
Symphogen A/SActive, not recruitingSym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor MalignanciesSolid Tumor | Metastatic CancerUnited States, Canada
-
Cancer Research UKBarinthus BiotherapeuticsSuspendedEsophageal Neoplasms | Non-small Cell Lung Cancer (NSCLC)United Kingdom
-
SanofiActive, not recruitingNon-small Cell Lung Cancer MetastaticKorea, Republic of, United States, Bulgaria, Czechia, Portugal, Spain
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
Effector TherapeuticsMedpace, Inc.; ICON plcActive, not recruitingNon-small Cell Lung CancerUnited States, Australia, Georgia
-
University of Texas Southwestern Medical CenterAstraZenecaActive, not recruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Regeneron PharmaceuticalsSanofiActive, not recruitingNon-small Cell Lung CancerUnited States, France, Korea, Republic of, Italy, Austria, China, Georgia, Greece, Ireland, Lithuania, Malaysia, Poland, Romania, Russian Federation, Slovakia, Thailand, Turkey, Ukraine
-
iOx TherapeuticsMerck Sharp & Dohme LLCTerminatedMelanoma | Non-small Cell Lung CancerSpain, United States, United Kingdom
-
Massachusetts General HospitalGenentech, Inc.Active, not recruitingNon-small Cell Lung CancerUnited States
-
Jazz PharmaceuticalsActive, not recruitingHER2-expressing CancersUnited States, Canada, Korea, Republic of
-
Seagen Inc.Merck Sharp & Dohme LLCTerminatedMelanoma | Small Cell Lung Cancer | Prostate Cancer | Gastric Adenocarcinoma | Head and Neck Squamous Cell Carcinoma | Esophageal Squamous Cell Carcinoma | Gastroesophageal Junction Adenocarcinoma | Non-small Cell Lung Cancer, Squamous | Non-small Cell Lung Cancer, Non-squamousUnited States, Korea, Republic of, Italy, United Kingdom, Australia, Taiwan
-
PfizerActive, not recruitingNon-small Cell Lung CancerUnited States, Spain, Netherlands, Korea, Republic of, Italy
-
Elicio TherapeuticsActive, not recruitingColorectal Cancer | Ovarian Cancer | Cholangiocarcinoma | Bile Duct Cancer | Non-small Cell Lung Cancer | Pancreatic Ductal Adenocarcinoma | Minimal Residual Disease | Gallbladder Carcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12RUnited States
-
Dana-Farber Cancer InstituteEli Lilly and CompanyTerminatedCarcinoma, Non-Small-Cell Lung | Solid TumorUnited States
-
Shenzhen TargetRx, Inc.Sun Yat-sen UniversityActive, not recruitingNon-small Cell Lung CancerChina
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingLung Cancer | Non-small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerUnited States, Australia, France, Germany, Korea, Republic of, New Zealand, Poland, Russian Federation, Spain, United Kingdom
-
AstraZenecaCompletedNon-small Cell Lung CancerItaly, Poland, France, Spain, United States, Russian Federation
-
Daiichi SankyoAstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Spain, Korea, Republic of, Italy, France, Japan, Taiwan, Netherlands, Australia, Canada
-
PfizerCompletedOvarian Cancer | Non-Small Cell Lung Cancer | Squamous Cell Carcinoma of the Head and NeckUnited States, Spain